WellDoc is developing and commercializing the next generation of technology to support patient and providers to improve management of chronic disease. Our mission is to improve the lives of people living with chronic disease by delivering a new category of therapy: mobile prescription therapy. We fulfill our mission by integrating clinical, behavioral, and motivational applications with everyday technologies such as the internet and smart phones. Our goal is to engage patients and healthcare providers in ways that dramatically improve clinical outcomes and significantly reduce healthcare costs.

WellDoc began commercializing our flagship product, BlueStar® for adults with type 2 diabetes in 2014. Learn more about BlueStar, the first mobile prescription therapy cleared by the FDA and prescribed by doctors that delivers real-time guidance to patients with type 2 diabetes at www.bluestardiabetes.com

Key News


Samsung reveals 24 digital health partners including Aetna, Cigna, Humana, WellDoc Read more »

WellDoc wins Baltimore Business Journal 2014 Health Care Innovators award Read more »

WellDoc, Inc. And American Diabetes Association's Maryland Chapter Announce A New Collaboration To Empower People With Type 2 Diabetes To Manage Their Condition Read more »

Go To Media Center